New eJournal: Med

Posted on by

The Library has subscribed to Med, a new journal published by Cell Press. The mission of the journal is to “accelerate translation of bench research to the clinic by providing a communication forum for the exchange of knowledge, fresh ideas, and thought-leadership among translational researchers, clinicians, and Biotech and Pharma scientists as well as other medical research stakeholders.”

Med is focused on research that will have an swift impact on clinical therapy. This research focus includes clinical studies, disease mechanism and/or therapies, biotechnology and engineering advances, and resources (such as informational databases) across a broad spectrum of medicine, cancer, obesity, heart disease, genetics, immunology, infectious diseases, and health economics and policy.

How To Receive Weekly Emails from The Cancer Letter

Posted on by

The Cancer Letter is “an independent weekly news publication” that provides information on “the development of cancer therapies, drug regulation, legislation, cancer research funding, health care finance, and public health”.

The MSK Library provides an institutional subscription to this publication. If you would like to receive email alerts, please follow these instructions to subscribe via email:

1. From the Library Website, in ONESEARCH, type Cancer Letter or click on the link to The Cancer Letter under eJournals
2. When prompted, authenticate by entering your MSK login credentials
3. Scroll down the page and click on News Alerts in the page footer (black bar)
4. Enter your name and email address and click Submit
5. You may need to click on the link in the email if you receive it to confirm subscription.

For more information on related publications and setting up journal alerts, email Ask-A-Librarian or call the general reference line at 212.639.7439.

Join us for “Separating What We Think from What We Know: A New Journal’s Approach”

Posted on by

Join us as we explore the clinical research environment and cover such topics as clinical trial design, evaluating clinical evidence, and contextualizing information into clinical practice.

Learn how NEJM Group editors are taking a novel approach in publishing research in support of the medical community via their new journal NEJM Evidence.Come listen to presentations from the following speakers and participate in an interactive panel discussion.

Date: Wednesday, December 8, 2021
Time: 12:00 PM – 1:30 PM
Location: Zoom Webinar – Register Now 

Speakers:

Jeffrey M. Drazen, MD, Editor-in-Chief
Jeff joined the New England Journal of Medicine (NEJM) as Editor-in-Chief in 2000 and was appointed Editor-in-Chief, NEJM Group, in 2012, serving in both roles until 2019. He is now NEJM Group Editor and Editor-in-Chief of NEJM Evidence.

Chana A. Sacks, MD, MPH, Executive Editor
Chana joined NEJM as a 2014-2015 NEJM Editorial Fellow and has served as Editor of Images in Clinical Medicine since 2016. She is Co-Director of the Massachusetts General Hospital (MGH) Center for Gun Violence Prevention and a Clinician-Investigator in the MGH’s Division of General Internal Medicine and Mongan Institute, where she is also a Health Policy Researcher.

C. Corey Hardin, MD, PhD, Deputy Editor
Corey joined NEJM as Reviews Editor in 2021. He is an Assistant Professor of Medicine at Harvard Medical School and a member of the joint Harvard-MIT Program in Health Sciences and Technology faculty.

Sharon-Lise T. Normand, MSc, PhD, Statistical Editor
Sharon-Lise joined NEJM as a Statistical Editor in 2017.  She is the S. James Adelstein Professor of Health Care Policy in the Department of Health Care Policy at Harvard Medical School and a Professor in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health.